Fasere: Digital Tools Will Address Africa’s Long-term Clinical Conditions

Medlitics, led by its founder and CEO Michael Fasere, emerged from the frustration of fragmented healthcare across Africa. Patients with chronic diseases like hypertension, diabetes, and cardiovascular conditions often bounced between hospitals, labs, pharmacies, and specialists, with no unified medical history. This led to episodic care, delayed interventions, duplicate tests, avoidable complications, and soaring healthcare costs.

Africa's healthcare systems were designed to treat acute illnesses, not the chronic conditions that now claim a growing share of lives. Fasere saw a need to shift healthcare from reactive treatment to proactive prevention. This is where Medlitics comes in, harnessing AI, remote monitoring, digital health records, and connected care into a single platform. The goal is to empower patients and provide clinicians with better tools to manage long-term conditions.

The company's core innovation lies in continuous data tracking. Medlitics aggregates health information from various sources - patient-reported outcomes, connected medical devices, lab results, medication adherence, lifestyle data, and virtual consultations. Using advanced AI, it analyzes long-term trends to spot subtle signs of worsening health before crisis hits.

Instead of reacting to isolated readings, the platform generates personalized risk scores, early warning alerts, and evidence-based recommendations that enable patients and clinicians to intervene early. Patients receive daily coaching, medication reminders, educational content, and personalized wellness advice. Clinicians get actionable alerts instead of raw data streams.

Designing Medlitics posed its own set of challenges given the infrastructure constraints in Africa. The company built an offline-first Progressive Web Application (PWA) that works seamlessly even without constant internet connectivity. This allows Medlitics to function across urban hospitals, rural clinics, community health programs, and remote regions.

Features like low-bandwidth optimization, mobile-first design, device independence, and secure local caching ensure the platform operates effectively in inconsistent connectivity scenarios.

Fasere recognized the importance of human oversight alongside AI insights. Every Meddy AI recommendation comes with supporting clinical evidence, risk confidence scores, historical trend analysis, clinical rationale, and escalation recommendations. High-risk cases are automatically flagged for clinician review. The AI operates under a "human-in-the-loop" governance model, ensuring final diagnoses, treatment decisions, prescriptions, and care plans remain the sole responsibility of licensed healthcare professionals.

This blend of AI augmentation and human oversight addresses the critical need for safety and trust in healthcare.

Recognizing that many patients lack expensive wearables, Medlitics has developed affordable vitals monitoring devices. These devices measure blood pressure, heart rate, and oxygen levels, providing high-quality data that feeds into the platform. Medlitics supports multiple data acquisition pathways, including manual patient reporting, Bluetooth-enabled consumer devices, hospital-grade equipment, pharmacy and lab integrations, and smartphone sensors.

The company's strategy emphasizes interoperability over proprietary hardware, allowing patients from varied income levels to participate in the digital health ecosystem while enabling hospitals, employers, NGOs, and insurers to integrate additional monitoring devices as needed.